Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,37990,1554,0.98 [0.94-1.03],0.4344371363513117
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,37372,363,0.94 [0.86-1.04],0.2413888783583313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,41439,287,1.03 [0.92-1.15],0.5898220330869176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,28618,1303,0.98 [0.92-1.03],0.3861332581588947
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,41345,193,0.96 [0.85-1.10],0.5945571461704847
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,38744,147,0.91 [0.78-1.05],0.2032922665485766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",43415,191,0.98 [0.85-1.11],0.7144887426088208
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,43421,127,1.02 [0.86-1.20],0.8454425522594274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,37858,98,1.07 [0.89-1.30],0.4577707154324258
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,42071,205,0.94 [0.83-1.07],0.3238527665707948
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,41997,131,0.85 [0.72-0.99],0.0376862058610015
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,43553,118,1.06 [0.89-1.25],0.5404265718315912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,43551,145,0.97 [0.83-1.13],0.703209437277585
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",43540,134,1.00 [0.85-1.17],0.9770250423648372
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,42988,96,1.03 [0.85-1.25],0.7476577612792696
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",41531,696,0.97 [0.90-1.04],0.361973207387666
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,41074,239,0.96 [0.86-1.09],0.5437310019121053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,41315,480,0.98 [0.90-1.06],0.5924401856048209
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",34933,112,0.88 [0.74-1.05],0.1447665907922568
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",34912,91,0.95 [0.78-1.15],0.6061377197291613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",35272,451,1.00 [0.92-1.10],0.9179533428106116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",35285,464,1.01 [0.92-1.10],0.877962219150488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",19801,575,0.97 [0.89-1.05],0.4108145882568677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15789,194,0.97 [0.85-1.11],0.7031045872215126
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",34910,89,0.89 [0.73-1.08],0.2240536982538848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,38996,1317,0.99 [0.94-1.05],0.7946849988178748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",41387,571,1.04 [0.96-1.13],0.3293883067998939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,42741,202,0.94 [0.83-1.07],0.3475317862386903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",43691,195,1.04 [0.91-1.19],0.5708819802757175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,43224,120,1.13 [0.95-1.34],0.1732308989425478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,43699,112,1.03 [0.86-1.22],0.7659830403865362
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Stomach,43782,81,0.99 [0.80-1.21],0.9048568613581264
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,43317,501,0.93 [0.86-1.01],0.0946804906679642
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,43708,192,0.93 [0.81-1.06],0.2520552579588634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,43712,151,0.90 [0.78-1.05],0.1707076674286024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",43611,91,0.92 [0.76-1.12],0.4144155653597318
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",43616,90,0.93 [0.77-1.13],0.4699013279070315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,43467,334,1.08 [0.97-1.20],0.1531735249178688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,43729,152,1.21 [1.04-1.42],0.0153398252302277
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,43542,305,1.04 [0.94-1.16],0.45599713875099
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of breast,23642,120,0.97 [0.82-1.15],0.7497740028973712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,23212,870,0.99 [0.93-1.06],0.7498137484706282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,41632,330,1.04 [0.94-1.15],0.4610301049269044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,41106,578,1.03 [0.95-1.11],0.507034193088675
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,41106,578,1.03 [0.95-1.11],0.507034193088675
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),37913,749,0.96 [0.89-1.02],0.1992744381525975
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,42854,117,0.80 [0.68-0.95],0.0083882025652778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,43284,134,0.97 [0.83-1.14],0.7060494721136282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,35472,1922,1.00 [0.95-1.04],0.8295479791777949
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,41244,916,1.03 [0.97-1.10],0.3879857337082316
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,39833,209,0.93 [0.82-1.06],0.2890659569633311
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,41772,186,0.94 [0.82-1.07],0.3528669024489206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,39812,188,0.94 [0.82-1.07],0.3361230542661575
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,40532,908,1.02 [0.95-1.09],0.5870489385372997
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,40507,883,1.01 [0.95-1.08],0.7377900383265319
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,40549,301,0.89 [0.79-1.00],0.0452561781027796
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",40552,298,0.89 [0.80-1.00],0.0542733870699959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,35183,1633,0.98 [0.94-1.03],0.5205854925868878
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",33759,209,0.94 [0.83-1.07],0.3759621879562721
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,35062,1512,0.99 [0.94-1.04],0.5909164907271675
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,33638,88,1.07 [0.88-1.31],0.4943870138323475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",33689,139,0.96 [0.82-1.12],0.5911785242076402
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,37088,1097,0.99 [0.93-1.05],0.680403577249338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",36382,391,0.94 [0.85-1.03],0.1929573445853938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",43099,284,0.95 [0.85-1.06],0.3443451776681812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",43203,206,0.98 [0.86-1.12],0.8174628805199939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Acute alcohol intoxication,40762,100,0.86 [0.72-1.03],0.1075930544349123
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",43623,100,0.87 [0.72-1.04],0.117865254957331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",36091,100,0.86 [0.72-1.03],0.1015808144418098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Alcohol dependence,40779,117,0.84 [0.71-0.99],0.0435431772461507
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,40685,107,0.95 [0.79-1.14],0.567535737493919
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",36088,97,0.94 [0.78-1.13],0.4836452025805429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",36525,534,1.01 [0.93-1.09],0.8637439364422468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Depression,41087,467,0.99 [0.91-1.08],0.8355002456206155
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Depression or dysthymia,36119,407,1.00 [0.91-1.10],0.9986238558132916
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",36204,213,1.04 [0.91-1.18],0.5848374234827662
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Other anxiety disorders,41298,110,0.95 [0.80-1.13],0.5523015561925377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,37645,2509,1.00 [0.96-1.04],0.9407987041754609
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,34208,235,1.00 [0.89-1.13],0.9976900890761886
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,43519,185,1.02 [0.89-1.17],0.7905704980230206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,41546,812,0.98 [0.91-1.04],0.4483412866702839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,40985,251,0.87 [0.77-0.97],0.0135039156880528
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,40870,136,1.00 [0.85-1.17],0.9990257866936548
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",43271,122,1.00 [0.85-1.19],0.9676555607522686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,42392,134,1.03 [0.88-1.21],0.7283314961197718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,41015,281,1.03 [0.92-1.15],0.6500924845343077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,42821,212,1.03 [0.90-1.17],0.704327800161906
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",41791,1126,1.02 [0.96-1.08],0.4755340667927344
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",40874,209,1.05 [0.93-1.20],0.4225761753147438
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,41315,650,1.02 [0.94-1.09],0.6824507392472905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,43289,139,1.04 [0.88-1.21],0.6715368108910904
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,43248,98,0.97 [0.81-1.17],0.7672825564893144
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,42954,201,0.87 [0.77-0.99],0.0358172167298947
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",42641,632,0.98 [0.91-1.06],0.6070020234625488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,42373,364,1.01 [0.91-1.11],0.8502358885321223
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,42137,128,0.94 [0.80-1.11],0.4909723726215167
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,42206,197,1.04 [0.91-1.19],0.5644279230459206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,42140,131,1.05 [0.89-1.24],0.5310725394954967
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,37694,265,0.97 [0.87-1.09],0.6612067757744408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,38112,683,0.99 [0.92-1.06],0.7198917573848918
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,42067,343,1.05 [0.95-1.16],0.3540550885279944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,43220,67,1.11 [0.88-1.40],0.3704904394121029
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,3721,67,1.06 [0.85-1.34],0.5998059678546168
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",39566,67,1.12 [0.89-1.41],0.336423856357817
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,42622,162,0.92 [0.79-1.06],0.227589374739846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,42546,86,1.02 [0.84-1.25],0.8237517079616121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",42601,141,0.92 [0.79-1.08],0.308592453946953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,42867,167,0.94 [0.81-1.08],0.3858355074410181
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,43595,227,0.98 [0.87-1.11],0.7974758779021955
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,42327,180,1.00 [0.87-1.15],0.9752504209464052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,30926,5450,0.98 [0.95-1.01],0.1590605991796976
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,42727,115,0.83 [0.70-0.98],0.025359845961671
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",32630,3743,1.01 [0.98-1.05],0.4660401842037778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,32672,3785,1.01 [0.98-1.05],0.4897657961726419
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,28983,96,0.94 [0.78-1.14],0.5410657881028902
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",40075,1965,0.96 [0.92-1.01],0.103138371034665
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,39275,1165,0.95 [0.89-1.00],0.0545953342519642
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,41998,380,1.01 [0.92-1.11],0.8659877356492146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,42395,777,0.97 [0.91-1.04],0.3619172182794909
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",43544,164,0.89 [0.77-1.02],0.1035507285707292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",38602,492,0.94 [0.86-1.02],0.13920377475982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,39627,1548,0.96 [0.92-1.01],0.1368995209480469
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,42360,188,0.93 [0.81-1.06],0.2875729265807383
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,42576,396,0.97 [0.88-1.07],0.5288175211109221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,42342,170,0.87 [0.76-1.00],0.0469882410710423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,42344,172,0.87 [0.76-1.00],0.0540042589744575
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",29050,163,0.88 [0.77-1.02],0.0868671017240836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,36389,101,0.97 [0.80-1.16],0.7054354024745245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,36486,198,0.88 [0.78-1.00],0.0592687909297361
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,24209,191,0.88 [0.77-1.01],0.065749458787502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,24763,745,0.87 [0.81-0.94],0.0001788522490549
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,36402,114,1.04 [0.87-1.24],0.6612334909655342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,36447,159,0.72 [0.63-0.83],3.642798322610024e-06
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",41985,350,0.97 [0.88-1.07],0.5620789013036387
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",42254,253,0.98 [0.87-1.10],0.6765222563449415
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",42312,212,0.99 [0.87-1.12],0.8728105117397049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",42443,185,1.00 [0.87-1.14],0.9763152102746164
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,41766,125,0.87 [0.74-1.02],0.0954149739466206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,41861,220,0.95 [0.84-1.07],0.4177583732987596
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),41282,245,1.02 [0.91-1.15],0.7303553453905519
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,41243,206,1.01 [0.88-1.15],0.9361584586434508
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",43401,198,1.04 [0.91-1.18],0.6089810326489399
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,41853,816,0.91 [0.85-0.97],0.0041863691767342
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,41800,141,0.94 [0.80-1.10],0.4260099450170985
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,34948,3531,1.02 [0.98-1.05],0.3342190485693187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,43454,189,1.01 [0.88-1.16],0.8699559391644791
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,40632,391,0.97 [0.88-1.06],0.4970770611572509
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",40580,339,0.97 [0.88-1.07],0.5334320779561994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,42186,440,0.95 [0.87-1.04],0.3048903318224991
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,42179,433,0.95 [0.87-1.04],0.2877971365247451
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,42389,1042,1.06 [1.00-1.13],0.0390160331497605
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,41513,166,1.09 [0.94-1.27],0.2361288482509024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,41558,211,1.14 [1.00-1.30],0.0474237558125843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",42010,663,1.06 [0.98-1.14],0.1216185204754494
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,41661,314,1.05 [0.94-1.16],0.4026041693987876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,20135,108,1.08 [0.90-1.30],0.4177463028420884
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,39062,1732,1.02 [0.97-1.07],0.4644893922864126
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,41774,302,1.02 [0.92-1.14],0.6973946472137535
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",41816,344,1.02 [0.92-1.13],0.6598342616205931
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",41816,344,1.02 [0.92-1.13],0.6598342616205931
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",40781,1419,1.01 [0.96-1.06],0.749810227785277
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Asthma,31248,1419,1.01 [0.96-1.07],0.6282528178227098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",30799,1419,1.01 [0.96-1.06],0.6431764356966263
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",31226,1397,1.01 [0.96-1.06],0.7103287953771393
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,43120,176,0.85 [0.74-0.97],0.0165630042238453
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,41189,136,0.85 [0.73-1.00],0.0435086144596612
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"ILD, hospital admissions",43252,136,0.85 [0.73-1.00],0.0435049682690535
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,41176,123,0.81 [0.69-0.95],0.0106642391500205
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,40248,189,0.95 [0.83-1.08],0.4098146671654183
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,40461,402,0.97 [0.89-1.07],0.536422721407448
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,41614,183,1.00 [0.87-1.14],0.9558475079404776
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,29877,9907,1.00 [0.97-1.02],0.7278635666425758
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",42884,716,1.00 [0.94-1.07],0.943359698900583
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,43724,144,1.00 [0.86-1.17],0.9952774340736992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,43730,133,1.00 [0.86-1.18],0.9589769518191992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,42357,189,1.07 [0.93-1.23],0.3360176408292473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,42342,174,1.05 [0.91-1.21],0.4868837834233259
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,43707,162,1.02 [0.88-1.18],0.7839327657914653
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,42330,162,0.96 [0.83-1.10],0.5431813306570332
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,41883,134,0.89 [0.76-1.04],0.1312596570425288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,43585,93,0.85 [0.70-1.02],0.0830442972313073
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,33352,463,0.96 [0.88-1.04],0.3208683060703268
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",36578,3689,0.97 [0.94-1.00],0.0895416072850024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,33467,578,1.04 [0.96-1.13],0.2911070362392624
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,34097,1208,0.97 [0.92-1.02],0.2547594946084489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,33024,135,1.00 [0.85-1.17],0.9682341500633174
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,33254,365,0.99 [0.90-1.10],0.8918126655840275
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,32990,101,1.06 [0.88-1.28],0.5348450534910747
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,33143,254,0.92 [0.82-1.03],0.1300270089860673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,33107,218,1.01 [0.89-1.15],0.8180999150439383
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",43551,154,1.02 [0.88-1.19],0.7636553041287328
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,33105,216,0.94 [0.83-1.06],0.3213935315243438
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),34262,1373,0.96 [0.91-1.01],0.0783558176933017
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,43513,221,1.06 [0.93-1.20],0.4004659751082515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,33622,733,0.99 [0.92-1.06],0.7509826578557148
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,33180,291,0.93 [0.83-1.03],0.1594310050290366
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,43493,270,0.96 [0.86-1.08],0.5038698109645117
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,43472,180,1.07 [0.93-1.23],0.348198040489597
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,38368,2784,1.00 [0.96-1.03],0.8177472157163455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,36609,1025,0.99 [0.93-1.05],0.7323846405915797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,35794,210,1.01 [0.89-1.15],0.8932997810266
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,35752,168,0.88 [0.76-1.01],0.069423015518427
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,37071,1487,1.01 [0.97-1.07],0.5652754422378621
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,42116,1308,1.05 [1.00-1.11],0.0620307990703144
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,34350,3427,0.98 [0.95-1.02],0.3392726218211715
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",43200,103,1.06 [0.88-1.27],0.5513988421637576
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",43662,138,1.10 [0.93-1.29],0.2619850311937227
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,40946,138,1.10 [0.94-1.29],0.2422032912113613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,40912,104,1.09 [0.90-1.31],0.378259600028181
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",43539,231,1.04 [0.92-1.18],0.5047207308938635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,41039,231,1.05 [0.92-1.18],0.4756990923737465
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",41013,205,1.03 [0.91-1.18],0.6263199883586752
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,41878,1070,1.04 [0.99-1.11],0.14328987114619
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,41866,1058,1.04 [0.98-1.11],0.1534508733337201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,31091,168,1.02 [0.88-1.18],0.7762405359158868
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal stricture,42992,168,1.03 [0.89-1.19],0.7068305239855917
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",31034,111,1.04 [0.87-1.24],0.7006596180814626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,31951,1028,0.98 [0.92-1.04],0.4453156315544617
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,31209,286,0.97 [0.87-1.08],0.5467497881934518
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,31406,483,1.03 [0.94-1.12],0.5370882533772252
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,41054,434,1.01 [0.92-1.10],0.8306370300351023
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,42997,144,1.00 [0.86-1.17],0.983939637473676
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,31170,247,1.00 [0.89-1.12],0.9690921476360717
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,31046,123,0.96 [0.81-1.13],0.589669884806213
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,32441,1518,0.99 [0.94-1.04],0.691346974477375
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,31388,465,0.91 [0.83-0.99],0.0297172756751633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,42973,120,1.02 [0.86-1.21],0.8263230903140028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,42390,210,0.74 [0.66-0.84],1.2660895366817103e-06
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,42297,117,0.77 [0.65-0.90],0.0012875361981102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",41416,1042,1.00 [0.94-1.06],0.9851676423426664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,41211,837,1.01 [0.94-1.07],0.8423016224955355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,40543,169,1.04 [0.90-1.21],0.555755288798929
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,40455,81,1.12 [0.90-1.38],0.3082074215305576
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,40485,111,0.91 [0.77-1.08],0.275014319201351
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),43468,111,0.91 [0.76-1.08],0.2579441116955334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,41436,521,1.08 [0.99-1.17],0.0714900156070132
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,41028,113,1.13 [0.94-1.35],0.195913354373954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,41010,95,1.12 [0.92-1.36],0.2738648550536228
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",40997,82,1.13 [0.92-1.40],0.2389629787031281
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,41250,335,1.06 [0.96-1.18],0.2415844684527335
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,41238,323,1.06 [0.95-1.17],0.2864283621657614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,38446,2651,0.97 [0.94-1.01],0.1466496751667493
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,43011,188,0.93 [0.82-1.07],0.3136135581681912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,43077,776,1.00 [0.93-1.07],0.9097090901645016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,41098,978,0.99 [0.93-1.05],0.8140669694420861
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,42214,684,0.97 [0.90-1.04],0.4002329382356495
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",41680,150,0.92 [0.79-1.06],0.2431247077989584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,41967,437,0.97 [0.89-1.06],0.5545631817250957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,43289,152,0.93 [0.80-1.08],0.3399460373850927
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,43254,117,0.98 [0.83-1.16],0.8272639518755969
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,43228,91,1.00 [0.82-1.21],0.9636924853681798
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,42402,101,1.14 [0.94-1.38],0.1698835246835508
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,42915,614,0.98 [0.91-1.06],0.5920839088367333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,40278,158,0.96 [0.83-1.11],0.5541689096335534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,40286,166,0.87 [0.76-1.00],0.0584135433256766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,40249,129,0.88 [0.75-1.04],0.1307856232811283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",40496,376,1.01 [0.92-1.11],0.8425008110216865
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,40461,341,0.98 [0.88-1.08],0.6885052154654041
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,31550,6793,1.00 [0.97-1.03],0.9344608273337784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,34300,3957,1.01 [0.98-1.04],0.5973316244311567
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,39447,2060,1.04 [1.00-1.09],0.0656472634533319
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,30606,263,1.06 [0.94-1.19],0.3164517643302852
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,31130,787,0.96 [0.90-1.03],0.2676017643357413
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",43052,252,1.07 [0.95-1.20],0.2900332444079522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,43068,228,1.07 [0.95-1.22],0.2580037037326737
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,32275,1932,1.04 [0.99-1.09],0.1002015140808511
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",36694,1932,1.04 [0.99-1.09],0.0955196841488172
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,30465,122,0.92 [0.78-1.09],0.3576752668186097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",42822,118,0.91 [0.77-1.08],0.2810811470506179
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,30706,363,0.90 [0.81-0.99],0.0280838884239045
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,30464,121,0.95 [0.80-1.13],0.5506203434495891
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,30820,477,1.06 [0.97-1.15],0.2098886662695254
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",43490,236,1.16 [1.03-1.32],0.0184445426248835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,31228,885,1.07 [1.00-1.14],0.0566826280367515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,30993,650,0.98 [0.91-1.06],0.6430456649740734
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,32558,2215,1.00 [0.95-1.04],0.8119759849934799
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),30463,120,1.03 [0.87-1.22],0.7183477022455138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),30744,401,0.95 [0.86-1.04],0.2830435500090142
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,30433,90,1.05 [0.86-1.29],0.6037519028690792
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),30447,104,1.01 [0.84-1.22],0.9048103912254176
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,31170,827,1.01 [0.94-1.08],0.8243372086117974
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,31056,713,1.00 [0.93-1.08],0.9391119702359292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,33890,480,0.99 [0.91-1.08],0.903126113968637
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,42804,243,0.92 [0.81-1.03],0.1396390633878116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,42659,98,1.11 [0.92-1.34],0.2853812743968512
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,37879,114,0.93 [0.79-1.11],0.4458757233013763
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,38277,512,0.88 [0.81-0.95],0.0017104313167488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,39361,1596,0.94 [0.89-0.98],0.0066214661802862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,38089,324,0.90 [0.81-1.00],0.0464704742990961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,37911,146,0.87 [0.75-1.01],0.0659799389979216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",39025,1260,0.95 [0.91-1.01],0.0876002031434413
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,37852,87,1.09 [0.89-1.33],0.4042569983211386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,38175,410,0.96 [0.88-1.06],0.4229103056832723
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,37941,176,1.01 [0.87-1.16],0.940764210170524
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,37895,130,0.97 [0.82-1.14],0.7188486511629999
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,37996,231,0.90 [0.79-1.01],0.0790986930060736
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,37878,113,0.95 [0.80-1.13],0.5476206235454352
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,38291,526,0.98 [0.90-1.07],0.6575857983634028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,37910,523,1.07 [0.99-1.16],0.0998793007595566
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,37500,113,1.04 [0.88-1.24],0.6387794075736386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,37534,147,0.98 [0.84-1.15],0.8166030465982046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,37557,170,1.19 [1.02-1.37],0.0243478285624
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",37474,87,1.01 [0.83-1.23],0.9342145749257268
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,37587,200,1.04 [0.91-1.19],0.5597194804583606
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],37566,179,1.00 [0.87-1.14],0.9460587655888052
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,37824,437,1.02 [0.93-1.12],0.6336631573934379
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,37485,98,0.99 [0.82-1.20],0.9362883768238218
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,37512,125,0.97 [0.83-1.15],0.752762830434919
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,37595,208,1.02 [0.89-1.16],0.8162864563161801
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,37494,107,0.90 [0.76-1.08],0.2604058657547533
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",38155,768,1.03 [0.96-1.10],0.4574471120932334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,37677,290,0.98 [0.88-1.10],0.7684281833375712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,37800,413,1.01 [0.92-1.11],0.776758353653877
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,40555,299,0.90 [0.81-1.00],0.0434954575825515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,40913,657,0.91 [0.85-0.98],0.011096247976721
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,40337,81,0.95 [0.77-1.16],0.5977607787412735
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,40349,93,0.98 [0.81-1.19],0.8762960794455407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,40422,166,0.92 [0.80-1.06],0.2470037871662362
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,34894,7225,0.98 [0.96-1.01],0.1458603001445783
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17324,1053,1.01 [0.95-1.07],0.8582157522838274
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,39549,378,1.00 [0.90-1.10],0.931738632448099
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,39283,112,1.09 [0.91-1.30],0.3596831029558792
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,39769,77,0.92 [0.75-1.14],0.4442218871341677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,39777,85,0.99 [0.81-1.21],0.9352425693800948
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,39793,101,0.93 [0.77-1.11],0.401847714447933
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,43146,402,1.00 [0.91-1.09],0.9357254887527108
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,43054,113,1.17 [0.98-1.41],0.0856250792255702
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,43034,290,0.99 [0.88-1.10],0.7924851200833807
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,42884,140,1.09 [0.93-1.28],0.3079065216143806
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,40095,1787,1.00 [0.95-1.04],0.944027216286944
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,38466,158,0.91 [0.79-1.05],0.2050040797862187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,38444,136,1.15 [0.98-1.35],0.093009138189446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,38768,460,0.99 [0.91-1.08],0.8745687427791382
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,38503,195,0.91 [0.80-1.04],0.1630582637152771
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,39482,1174,1.02 [0.97-1.08],0.4714229065396156
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16747,476,1.03 [0.94-1.12],0.5215212503532374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16359,88,0.95 [0.78-1.16],0.6196629952230801
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydrocele,16358,87,1.02 [0.83-1.25],0.8451667309231892
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16404,133,0.97 [0.83-1.14],0.7042242163764547
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16403,132,1.08 [0.92-1.28],0.3449156174849832
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16439,168,0.95 [0.83-1.10],0.4980422471918236
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23431,416,0.91 [0.83-1.00],0.042863384976954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23145,130,0.91 [0.78-1.07],0.2783541585457708
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23159,144,0.97 [0.83-1.13],0.6947538862516238
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23113,98,0.83 [0.69-0.99],0.0397433687437688
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23369,484,1.00 [0.91-1.08],0.9124866160232542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23003,118,0.98 [0.83-1.16],0.8074826589938604
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23100,215,1.02 [0.90-1.16],0.7736654755612399
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,21619,3960,0.99 [0.96-1.02],0.4628295224840447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,17960,301,1.05 [0.94-1.18],0.3605828178440123
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,17741,82,1.29 [1.04-1.61],0.0209741416437229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17801,142,1.01 [0.86-1.18],0.940066819951304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18345,686,1.05 [0.97-1.13],0.2081229087467394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18008,349,0.94 [0.85-1.04],0.2023904265186383
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18480,821,0.96 [0.89-1.02],0.1739258366812368
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,17928,269,0.89 [0.80-1.00],0.0497765938397384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18039,380,1.01 [0.92-1.12],0.8046684586483721
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,17747,88,1.17 [0.95-1.43],0.1417674609869049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,17827,168,1.07 [0.92-1.24],0.3696305386804084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",23657,229,1.09 [0.96-1.24],0.1623795748658978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,23668,217,1.10 [0.96-1.25],0.1630150723050124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,23689,116,1.21 [1.01-1.44],0.0426460370226282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",23679,128,1.19 [1.00-1.42],0.0449036347611908
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17787,128,0.92 [0.78-1.08],0.3237145197451905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17763,104,0.96 [0.80-1.15],0.6591339128441683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17783,124,1.01 [0.85-1.19],0.9349282529468464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Irregular menses,23602,398,1.11 [1.01-1.22],0.0332279102224435
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",18822,1163,1.02 [0.96-1.08],0.474696912008683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Menorrhagia,18423,764,0.99 [0.93-1.06],0.8146438060901651
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",23677,173,1.02 [0.88-1.17],0.8035476381467883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18061,402,0.96 [0.88-1.05],0.398473531717694
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17928,269,0.95 [0.85-1.07],0.4168257038786778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18433,774,0.93 [0.87-1.00],0.0485259816512635
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female infertility,17742,83,1.11 [0.89-1.38],0.3469533834722135
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",17735,76,1.08 [0.86-1.35],0.5063236516344914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,23684,720,1.00 [0.93-1.08],0.9542381207330072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,23690,987,1.03 [0.96-1.11],0.3479160681904476
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,23684,380,1.13 [1.02-1.26],0.0179811166559835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23411,107,1.16 [0.96-1.40],0.1272956421562432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23452,148,1.02 [0.87-1.19],0.8421996249837328
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23441,137,1.30 [1.09-1.54],0.0029756223489077
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",23701,143,0.97 [0.83-1.13],0.6965656069179713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,23703,140,0.97 [0.83-1.14],0.7553330362083979
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,23701,353,0.91 [0.82-1.01],0.0913748923309053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23453,105,0.81 [0.68-0.97],0.0243038312621905
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23544,196,0.94 [0.82-1.08],0.361390314953625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23087,123,1.07 [0.89-1.27],0.4716550910734894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23130,166,1.01 [0.87-1.18],0.8517763268037024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23165,201,0.99 [0.86-1.13],0.8399336606415466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23086,122,0.99 [0.83-1.17],0.8692163804348224
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",False labour,23076,112,1.09 [0.91-1.31],0.3626117290165408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23090,126,0.87 [0.74-1.03],0.1106270097097914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Long labour,22887,184,1.09 [0.94-1.25],0.2603125099219425
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23068,365,1.02 [0.92-1.13],0.7368983564357727
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23251,548,1.08 [0.99-1.18],0.0785598508093881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",23705,144,1.04 [0.88-1.22],0.6578829584530714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22508,110,1.02 [0.85-1.22],0.8111601211100824
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",22787,84,1.01 [0.82-1.25],0.90750898032312
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Delivery,23711,279,0.93 [0.83-1.05],0.2510245885885158
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,23648,216,0.93 [0.81-1.06],0.2637468084022288
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",23700,214,1.06 [0.93-1.22],0.377662232346636
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",23690,204,1.06 [0.92-1.21],0.4332062128703424
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",43119,101,0.87 [0.73-1.05],0.1457288239085067
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,39548,994,0.92 [0.86-0.97],0.0038425906112223
